Last News
-
20-10-2008: Ontaril® closer to the market
Cellerix ends the recruitment for the first Phase III trial
It is sticking to the planned schedule, which is expected to be commercialized by 2011
-
12-10-2008: Joël Jean-Mairet to become Chairman of Cellerix
Eduardo González appointed Director.
-
30-09-2008: Cellerix obtains a 10M€ debt facility with ETV Capital
The biopharmaceutical company will be able to finalize clinical development of Ontaril®, its treatment for Perianal Fistulas for Crohn and non-Crohn patients.
-
14-04-2008: Cellerix registers the name Ontaril® for its medicine Cx401
Cellerix has registered the name Ontaril® for its medicine Cx401.
-
19-02-2008: The Lilly Foundation and Cellerix present the book “Cell Therapy”
Cell Therapy is the first book in the world published about a field that is revolutionizing medical practice